非抗菌药物静脉给药至口服给药转换的“大临床数据”分析
"Big Clinical Data" Analysis of Intravenous to Oral Conversions of Non-Antimicrobials.
作者信息
Beeler Patrick E, Bates David W, Blaser Jürg
机构信息
Research Center for Medical Informatics, University Hospital Zurich & University of Zurich, Switzerland.
Division of General Internal Medicine, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
出版信息
Stud Health Technol Inform. 2017;245:1251.
Advantages of early intravenous (IV) to oral (PO) switches of antimicrobials are well known. Yet, little data have been published on reasonable IV-to-PO switches of other drug classes, although interventions to promote early IV-to-PO conversions may further increase patient safety and decrease costs. We therefore analyzed IV-to-PO switches of non-antimicrobials.
抗菌药物早期从静脉注射（IV）转换为口服（PO）的优势已广为人知。然而，关于其他药物类别合理的从静脉注射到口服转换的数据却鲜有发表，尽管促进早期从静脉注射到口服转换的干预措施可能会进一步提高患者安全性并降低成本。因此，我们分析了非抗菌药物的从静脉注射到口服的转换情况。
Zotero 插件